Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

FOUR

Shift4 Payments Inc

Mar 11 • 09:30AM ET

47.15

+0.27 0.58 %

Technology • Software - Infrastructure • USA • NYSE

Peers: XYZ V MA PYPL GPN FIS WEX PAYC JKHY XP

| Held by: VTI IJH VB VBK VXF MDY IWP XMMO SCHA SPMD

Index	-	P/E	43.99	EPS (ttm)	1.07	Insider Own	35.46%	Shs Outstand	63.67M	Perf Week	-5.49%
Market Cap	4.82B	Forward P/E	6.90	EPS next Y	6.83	Insider Trans	1.01%	Shs Float	53.15M	Perf Month	-20.46%
Enterprise Value	9.61B	PEG	0.42	EPS next Q	0.96	Inst Own	99.54%	Short Float	30.48%	Perf Quarter	-31.55%
Income	78.20M	P/S	1.15	EPS this Y	8.33%	Inst Trans	-7.27%	Short Ratio	7.08	Perf Half Y	-46.00%
Sales	4.18B	P/B	6.51	EPS next Y	21.93%	ROA	1.71%	Short Interest	16.20M	Perf YTD	-25.12%
Book/sh	7.24	P/C	3.67	EPS next 5Y	16.27%	ROE	10.48%	52W High	108.50 -56.54%	Perf Year	-46.95%
Cash/sh	12.86	P/FCF	9.65	EPS past 3/5Y	1.00% -	ROIC	1.30%	52W Low	43.32 8.84%	Perf 3Y	-30.98%
Dividend Est.	-	EV/EBITDA	11.26	Sales past 3/5Y	27.99% 40.37%	Gross Margin	27.23%	Volatility	4.46% 5.66%	Perf 5Y	-50.23%
Dividend TTM	-	EV/Sales	2.30	EPS Y/Y TTM	-65.33%	Oper. Margin	10.07%	ATR (14)	3.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.66	Sales Y/Y TTM	25.51%	Profit Margin	1.87%	RSI (14)	36.43	Recom	1.88
Dividend Gr. 3/5Y	- -	Current Ratio	1.66	EPS Q/Q	-73.94%	SMA20	-10.08%	Beta	1.62	Target Price	64.43
Payout	0.00%	Debt/Eq	3.20	Sales Q/Q	34.05%	SMA50	-19.55%	Rel Volume	0.88	Prev Close	46.88
Employees	6300	LT Debt/Eq	3.18	Earnings	Feb 26 BMO	SMA200	-39.39%	Avg Volume	2.29M	Price	47.15
IPO	Jun 05, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.14% -1.26%	Trades		Volume	100,949	Change	0.58%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-17-25	Resumed	Deutsche Bank	Buy	$120
Jun-02-25	Initiated	Truist	Hold	$97
Mar-10-25	Upgrade	Raymond James	Outperform → Strong Buy	$140
Feb-03-25	Initiated	Deutsche Bank	Hold	$120
Dec-09-24	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$112
Dec-05-24	Downgrade	The Benchmark Company	Buy → Hold
Dec-04-24	Downgrade	BofA Securities	Buy → Neutral
Oct-09-24	Initiated	Barclays	Overweight	$120
Oct-01-24	Initiated	Oppenheimer	Outperform	$109
Sep-04-24	Initiated	William Blair	Outperform
May-24-24	Initiated	Wedbush	Neutral	$75
Apr-19-24	Upgrade	Redburn Atlantic	Sell → Neutral	$53
Feb-13-24	Initiated	The Benchmark Company	Buy	$95
Jan-16-24	Initiated	Keefe Bruyette	Outperform	$95
Dec-14-23	Initiated	Seaport Research Partners	Buy	$85
Dec-06-23	Initiated	Redburn Atlantic	Sell	$49
Oct-31-23	Initiated	Wells Fargo	Overweight	$55
Oct-20-23	Resumed	UBS	Buy	$75
Oct-06-23	Initiated	Berenberg	Buy	$87
Aug-25-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$52 → $57

Show Previous Ratings

Mar-10-26 06:25AM	Shift4 Payments vs Corpay: Two Fintech Giants Fighting for the Future of Payments (24/7 Wall St.)
12:04AM	Shift4 (FOUR): 3 Reasons We Love This Stock (StockStory)
Mar-09-26 04:05PM	Shift4 Announces Executive Promotions and Leadership Changes (Business Wire)
Mar-08-26 12:25PM	Benchmark Reaffirms Buy Rating on Shift4 Payments (FOUR) (Insider Monkey)
Mar-07-26 01:31PM	NASA Eyes Boeing-Lockheed Rocket Component For Moon Mission As Costs Skyrocket: Report (Benzinga)
10:59PM	Loading…
Mar-04-26 10:59PM	NASA Eyes Boeing-Lockheed Rocket Component For Moon Mission As Costs Skyrocket: Report (Benzinga)
08:30AM	Exclusive: Cyclops raises $8 million to build stablecoin infrastructure for payments companies (Fortune)
Mar-03-26 03:35PM	Shift4 (FOUR) Shares Skyrocket, What You Need To Know (StockStory) +6.28%
05:30AM	Shift4 taps xAI for customer service (Payments Dive)
Mar-02-26 04:30PM	Shift4 Completes Previously Announced Acquisition of Worldline's North American Subsidiaries (Business Wire) +6.51%
03:30PM	Why Are Shift4 (FOUR) Shares Soaring Today (StockStory)
09:48AM	B. Riley Reduces Target Price on Shift4 Payments (FOUR) to $120, Post Q4 Earnings (Insider Monkey)
Feb-28-26 03:20AM	Shift4 Payments Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 03:26PM	Shift4, Affirm, Voya Financial, StepStone Group, and Ares Stocks Trade Down, What You Need To Know (StockStory) -8.97%
08:30AM	Shift4 Payments, Inc. Q4 2025 Earnings Call Summary (Moby)
06:13AM	Loading…
06:13AM	Shift4 Payments (FOUR) Falls to 2-Year Low as Profits Plunge 65% (Insider Monkey)
Feb-26-26 04:08PM	Shift4 Payments Inc (FOUR) Q4 2025 Earnings Call Highlights: Record Growth and Strategic ... (GuruFocus.com) -15.62%
12:30PM	Compared to Estimates, Shift4 Payments (FOUR) Q4 Earnings: A Look at Key Metrics (Zacks)
12:28PM	Nvidia Slumps Over 4%, Wall Street's Fear Gauge Rallies: What's Moving Markets Thursday? (Benzinga)
12:25PM	Why Shift4 (FOUR) Shares Are Plunging Today (StockStory)
12:15PM	Shift4 Payments (FOUR) Q4 Earnings Surpass Estimates (Zacks)
12:08PM	Why Shift4 Payments Stock Just Hit 52-Week Low (Benzinga)
11:42AM	Shift4 Payments Q4 Volume Up 23% Amid International Expansion (Exec Edge)
08:02AM	Shift4 Payments: Q4 Earnings Snapshot (Associated Press Finance)
07:47AM	Shift4's (NYSE:FOUR) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
07:00AM	Shift4 Announces Fourth Quarter 2025 Results (Business Wire)
Feb-25-26 07:22AM	Shift4 Payments Inc (FOUR) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
07:00AM	Trump Left This Out Of The State Of The Union- And It Could Affect Elon Musk's Lunar Plans (Benzinga)
Feb-24-26 10:11PM	What To Expect From Shift4's (FOUR) Q4 Earnings (StockStory)
09:15AM	Stay Ahead of the Game With Shift4 Payments (FOUR) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:25PM	Loading…
Feb-23-26 07:25PM	Paymentus (PAY) Q4 Earnings and Revenues Surpass Estimates (Zacks)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
Feb-16-26 10:45AM	Shift4 Payments (FOUR) Remains in Focus Amid Volatility in Payment Technology Stocks (Insider Monkey)
Feb-13-26 11:08AM	Shift4 Payments CEO Taylor Lauber Talks Firms Tremendous Growth at ICR (NYSE)
Feb-12-26 04:30PM	Shift4 Announces Date of Fourth Quarter Earnings Results and Upcoming Investor Conference Participation (Business Wire) -7.10%
Feb-11-26 10:00AM	Global Payments (GPN) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-10-26 10:00AM	Shift4 Payments (FOUR) Earnings Expected to Grow: Should You Buy? (Zacks)
08:15AM	Fiserv (FISV) Q4 Earnings Beat Estimates (Zacks)
Feb-09-26 04:30PM	Shift4 Payments, Inc., Now a Single Share Class Company, Removing Super-Voting Stock, and Eliminating Tax Receivable Obligations to Founder (Business Wire)
Feb-08-26 08:31AM	US-China Space Race Just Heated Up As Xi Jinping-Led Nation Wants Orbital Datacenters, Space Tourism (Benzinga)
Jan-28-26 12:05PM	1 Fintech Stock Set to Rebound in 2026 (Motley Fool)
Jan-22-26 11:09AM	Shift4 Payments CEO Taylor Lauber on Powering Merchants: ICR Conference 2026 (Exec Edge)
04:33AM	Why Shift4 targets big merchants (Payments Dive)
03:19AM	Analysts See Mixed Outlook for Shift4 Payments, Inc. (FOUR) Amid Fintech Sector Risks (Insider Monkey)
Jan-19-26 06:01PM	Shift4 Payments, Inc. (FOUR): A Bull Case Theory (Insider Monkey)
Jan-16-26 06:20PM	Big Buying Opportunity In These 3 Cheap Growth Stocks (Motley Fool)
Jan-15-26 02:36PM	Sneak Preview of 33 C-Suite Interviews at ICR Conference 2026 (Exec Edge)
Jan-13-26 02:13AM	Elon Musk Says SpaceX Wants To Make 'Star Trek Real' Amid Pete Hegseth's Starbase Visit (Benzinga)
Jan-12-26 11:47PM	Secretary Of War Pete Hegseth Visits Elon Musk-Led SpaceX's Starbase - Touts Grok Integration At Pentagon: 'There Is Nothing Like This...' (Benzinga)
11:04PM	Shift4 (FOUR): 3 Reasons We Love This Stock (StockStory)
07:35AM	My 5 Favorite Stocks to Buy Right Now (Motley Fool)
04:31AM	Trump's NASA Administrator Jared Isaacman Reaffirms Commitment To Mars, Artemis Mission: 'We're Gonna Build Nuclear Spaceships' (Benzinga)
Jan-09-26 05:05AM	This Fintech Stock Poised for Explosive Growth Could Surge Over 100% by 2028. (Motley Fool)
Jan-07-26 06:07PM	CorpGov Showcases Conference Video Coverage Capabilities (CorpGov.com)
11:46AM	CorpGov to Host On-Site Interviews at ICR Conference 2026 (CorpGov.com)
09:44AM	What Makes Shift4 Payments (FOUR) an Investment Bet? (Insider Monkey)
08:00AM	Forbes Honors Shift4 as one of Americas Most Successful MidCap Companies for 2026 (Business Wire)
Jan-05-26 05:12PM	Shift4 Announces Third Dividend Date for Mandatory Convertible Preferred Stock (Business Wire)
Dec-29-25 10:50AM	6 Multibagger Stocks to Buy Before They Explode in 2026 (Motley Fool)
09:56AM	DA Davidson Affirms Buy Rating as Shift4 Payments Inc. (FOUR) Founder Joins NASA (Insider Monkey)
Dec-23-25 08:34AM	Is the Options Market Predicting a Spike in Shift4 Payments Stock? (Zacks)
05:24AM	Klarna, Shift4 embrace stablecoins (Payments Dive)
Dec-22-25 04:04PM	Shift4 Launches Stablecoin Settlements For Merchants, Shares Climb (Investor's Business Daily)
08:00AM	Shift4 Launches Global Stablecoin Settlement Platform, Unlocking Faster Payments for Merchants (Business Wire)
Dec-19-25 09:50AM	These Undervalued Growth Stocks Could Surge 50% by 2026 (Motley Fool)
Dec-18-25 06:38PM	Shift4 Celebrates Jared Isaacman's Appointment as NASA Administrator (Business Wire)
02:25AM	Why Freedom Capital Views Shift4 Payments as an Attractive Buy Amid Leadership Changes and Global Blue Integration (Insider Monkey)
Dec-11-25 09:39AM	PayPal downgraded, Roku upgraded: Wall Street's top analyst calls (The Fly)
09:17AM	Here Are Thursdays Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More (24/7 Wall St.)
09:17AM	Crypto Market 2026 Predictions: Which Coins Will 10x and Which Will Crash? (24/7 Wall St.)
Dec-10-25 08:54AM	Here's Why Shift4 Payments Inc. (FOUR) Declined -21.9% in Q3 (Insider Monkey)
Dec-04-25 01:39PM	Shift4 Payments, Inc. (FOUR): A Bull Case Theory (Insider Monkey)
Dec-03-25 06:53PM	Shift4 Payments Announces Pricing of 435 million Tack-On Offering of Senior Notes due 2033 (Business Wire)
Dec-02-25 08:00AM	Liberty Sports Group and Front Row Hospitality Announce Multi-Year Partnership with Shift4 to Power Commerce Across Sports, Entertainment, and Hospitality Properties (Business Wire)
03:35AM	Shift4 Payments Announces 435 million Tack-On Offering of Senior Notes due 2033 (Business Wire)
Nov-25-25 08:28AM	Truist Lowers Shift4 Payments (FOUR) PT $74 on Uncertainty Over 2026 Organic Volume in Hospitality, Restaurant Sectors (Insider Monkey)
Nov-21-25 05:51PM	Why Is Shift4 (FOUR) Stock Rocketing Higher Today (StockStory) +5.20%
04:00PM	Shift4 to Participate in Upcoming Investor Conference (Business Wire)
Nov-19-25 08:00AM	Shift4 Makes Canadian Sports Debut Powering Commerce for the Ottawa Senators (Business Wire)
Nov-18-25 05:15AM	4 Growth Stocks to Buy After the Recent Crash (Motley Fool)
Nov-12-25 11:58AM	3 Beaten-Down Stocks to Buy Before It's Too Late (Motley Fool)
08:00AM	Cincinnati Bengals Partner With Shift4 to Enhance Payment Technology at Paycor Stadium (Business Wire)
Nov-06-25 01:55PM	Why Shift4 (FOUR) Stock Is Trading Up Today (StockStory)
09:30AM	Shift4 Payments (FOUR) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:39AM	Shift4 (NYSE:FOUR) Reports Q3 In Line With Expectations, Stock Soars (StockStory)
08:30AM	Shift4 Payments (FOUR) Q3 Earnings and Revenues Top Estimates (Zacks)
07:25AM	Shift4 Payments: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Shift4 Announces Third Quarter 2025 Results (Business Wire)
Nov-05-25 09:15AM	Insights Into Shift4 Payments (FOUR) Q3: Wall Street Projections for Key Metrics (Zacks)
07:27AM	What To Expect From Shift4 Payments Inc (FOUR) Q3 2025 Earnings (GuruFocus.com)
Nov-04-25 10:21PM	Shift4 (FOUR) Q3 Earnings: What To Expect (StockStory)
09:10PM	Pres. Trump re-nominates fmr. Shift4 Payments CEO Jared Isaacman to be head of NASA (CNBC TV)
Oct-31-25 10:29PM	D.A. Davidson Lowers PT on Shift4 Payments (FOUR), Keeps a Buy (Insider Monkey)
Oct-30-25 10:00AM	Shift4 Payments (FOUR) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -5.28%
Oct-29-25 02:11PM	Why Shift4 (FOUR) Stock Is Trading Lower Today (StockStory) -6.84%
Oct-28-25 12:01AM	3 Reasons FOUR Has Explosive Upside Potential (StockStory)
Oct-22-25 06:25AM	Shift4 to buy Worldline subsidiaries (Payments Dive)
Oct-21-25 04:30PM	Shift4 To Acquire Worldlines North American Subsidiaries (Business Wire)
Oct-17-25 09:54PM	Raymond James Cuts Shift4 Payments (FOUR) PT, Keeps Strong Buy Rating (Insider Monkey)
Oct-16-25 04:30PM	Shift4 Announces Date of Third Quarter Earnings Results and Upcoming Investor Conference Participation (Business Wire)

Shift4 Payments, Inc. is an independent provider, which engages in the provision of payment acceptance and payment processing technology solutions in the U.S. based on total volume of payments processed. It operates through the U.S. and International geographical segments. The company was founded by Jared Isaacman in 1999 and is headquartered in Center Valley, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Isaacman Jared	10% Owner	Mar 10 '26	Buy	45.75	43,827	2,004,879	1,410,727	Mar 11 06:01 AM
Isaacman Jared	10% Owner	Mar 02 '26	Buy	43.83	45,693	2,002,948	1,366,900	Mar 04 06:07 AM
Isaacman Jared	10% Owner	Feb 27 '26	Buy	44.15	159,244	7,030,416	1,321,207	Mar 02 06:10 AM
Isaacman Jared	10% Owner	Feb 26 '26	Buy	48.38	136,993	6,627,845	1,161,963	Mar 02 06:10 AM
Disman Nancy	Director	Dec 11 '25	Sale	69.50	5,000	347,500	130,420	Dec 15 08:49 PM
Lauber David Taylor	Chief Executive Officer	Dec 11 '25	Sale	69.00	12,000	828,031	273,588	Dec 15 08:49 PM
Disman Nancy	Director	Dec 11 '25	Proposed Sale	69.50	5,000	347,500		Dec 11 04:20 PM
Lauber David Taylor	Officer	Dec 11 '25	Proposed Sale	69.00	12,000	828,031		Dec 11 04:20 PM
Whalen James J.	See Remarks	Nov 12 '25	Sale	71.50	1,438	102,817	54,736	Nov 14 04:05 PM
Whalen James J.	Officer	Nov 12 '25	Proposed Sale	71.50	1,438	102,817		Nov 12 04:50 PM
Disman Nancy	Chief Financial Officer	Sep 15 '25	Sale	87.28	5,000	436,404	135,420	Sep 17 04:05 PM
Disman Nancy	Director	Sep 15 '25	Proposed Sale	87.28	5,000	436,404		Sep 15 04:13 PM
Lauber David Taylor	Chief Executive Officer	Sep 03 '25	Sale	88.59	2,500	221,475	285,588	Sep 05 04:15 PM
Lauber David Taylor	Officer	Sep 03 '25	Proposed Sale	88.59	2,500	221,475		Sep 03 04:02 PM
Whalen James J.	See Remarks	Aug 15 '25	Sale	89.89	794	71,377	56,324	Aug 19 07:59 PM
Whalen James J.	Officer	Aug 15 '25	Proposed Sale	89.90	794	71,377		Aug 15 04:20 PM
Isaacman Jared	Executive Chairman	Aug 11 '25	Buy	83.61	104,705	8,754,040	939,715	Aug 11 04:47 PM
Isaacman Jared	Executive Chairman	Aug 08 '25	Buy	81.90	91,721	7,512,143	835,010	Aug 11 04:47 PM
Davis Karen Roter	Director	Jun 30 '25	Proposed Sale	100.00	750	75,000		Jun 30 04:04 PM
Goldsmith-Grover Sarah	Director	Jun 30 '25	Proposed Sale	100.00	2,957	295,700		Jun 30 04:04 PM
Disman Nancy	Chief Financial Officer	Jun 16 '25	Sale	90.33	10,000	903,319	167,622	Jun 17 08:54 PM
Davis Karen Roter	Director	Jun 12 '25	Sale	94.53	2,757	260,619	6,592	Jun 16 09:32 PM
Goldsmith-Grover Sarah	Director	Jun 12 '25	Sale	94.53	1,000	94,530	7,474	Jun 16 09:31 PM
Disman Nancy	Officer	Jun 16 '25	Proposed Sale	90.33	10,000	903,319		Jun 16 04:19 PM
Davis Karen Roter	Director	Jun 12 '25	Proposed Sale	94.53	2,757	260,619		Jun 16 04:13 PM
Goldsmith-Grover Sarah	Director	Jun 12 '25	Proposed Sale	94.53	1,000	94,530		Jun 12 04:19 PM
Frankel Jordan	See Remarks	Jun 09 '25	Sale	94.57	5,000	472,864	227,454	Jun 10 04:15 PM
Frankel Jordan	Officer	Jun 09 '25	Proposed Sale	94.57	5,000	472,865		Jun 09 04:09 PM
Lauber David Taylor	Chief Executive Officer	Jun 03 '25	Sale	94.47	2,500	236,175	256,981	Jun 05 04:15 PM
Lauber David Taylor	Officer	Jun 03 '25	Proposed Sale	94.47	2,500	236,175		Jun 03 04:22 PM
Disman Nancy	Chief Financial Officer	Mar 14 '25	Sale	84.98	10,000	849,790	177,622	Mar 17 05:23 PM
Disman Nancy	Officer	Mar 14 '25	Proposed Sale	84.98	10,000	849,790		Mar 14 04:38 PM

Open in Screener

SOLV

Solventum Corp

Mar 11 • 09:30AM ET

67.46

-0.14 -0.21 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: SHW PPG AXTA ECL RPM VAL FUL AVNT CC ALB

| Held by: VTI VOO VB VBR RSP IVV SPY XLV IWR VHT

Index	S&P 500	P/E	7.60	EPS (ttm)	8.87	Insider Own	14.93%	Shs Outstand	173.49M	Perf Week	-4.73%
Market Cap	11.70B	Forward P/E	9.54	EPS next Y	7.07	Insider Trans	0.01%	Shs Float	147.59M	Perf Month	-13.65%
Enterprise Value	16.07B	PEG	1.11	EPS next Q	1.35	Inst Own	73.25%	Short Float	2.36%	Perf Quarter	-21.03%
Income	1.56B	P/S	1.40	EPS this Y	5.98%	Inst Trans	1.48%	Short Ratio	3.22	Perf Half Y	-9.57%
Sales	8.35B	P/B	2.32	EPS next Y	9.15%	ROA	10.82%	Short Interest	3.49M	Perf YTD	-14.87%
Book/sh	29.10	P/C	13.33	EPS next 5Y	8.62%	ROE	38.86%	52W High	88.20 -23.51%	Perf Year	-11.11%
Cash/sh	5.06	P/FCF	-	EPS past 3/5Y	4.51% 1.23%	ROIC	15.22%	52W Low	60.70 11.14%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	10.56	Sales past 3/5Y	0.79% 0.47%	Gross Margin	56.63%	Volatility	2.55% 3.06%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.93	EPS Y/Y TTM	223.24%	Oper. Margin	12.53%	ATR (14)	2.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.89	Sales Y/Y TTM	1.14%	Profit Margin	18.64%	RSI (14)	29.64	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.23	EPS Q/Q	108.61%	SMA20	-7.50%	Beta	0.64	Target Price	91.91
Payout	0.00%	Debt/Eq	1.04	Sales Q/Q	-3.66%	SMA50	-12.41%	Rel Volume	0.42	Prev Close	67.60
Employees	20000	LT Debt/Eq	1.03	Earnings	Feb 26 AMC	SMA200	-10.38%	Avg Volume	1.08M	Price	67.46
IPO	Mar 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.03% 1.84%	Trades		Volume	22,833	Change	-0.21%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-26-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$97
Jan-20-26	Upgrade	Mizuho	Neutral → Outperform	$100
Dec-02-25	Upgrade	BTIG Research	Neutral → Buy	$100
Oct-01-25	Initiated	UBS	Neutral	$77
Sep-11-25	Initiated	Jefferies	Hold	$80
Jul-15-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$103
Jul-01-25	Upgrade	Argus	Hold → Buy	$90
Jun-06-25	Initiated	KeyBanc Capital Markets	Sector Weight
May-19-25	Upgrade	Piper Sandler	Neutral → Overweight	$87
Dec-04-24	Initiated	Mizuho	Neutral	$70
Oct-08-24	Initiated	Stifel	Buy	$82
Oct-07-24	Initiated	Piper Sandler	Neutral	$71
Sep-26-24	Initiated	Wolfe Research	Peer Perform
Sep-05-24	Initiated	BTIG Research	Neutral
Jun-24-24	Initiated	Argus	Hold
May-30-24	Initiated	Goldman	Sell	$54
May-10-24	Initiated	BofA Securities	Neutral	$70
Apr-10-24	Initiated	Morgan Stanley	Equal-Weight	$70
Apr-08-24	Initiated	Wells Fargo	Equal Weight	$69
Apr-02-24	Initiated	Edward Jones	Hold

Show Previous Ratings

Mar-06-26 07:00AM	Middleby Appoints Glenn Eisenberg To Board of Directors (Business Wire)
Mar-05-26 11:22AM	Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth (Insider Monkey)
Mar-03-26 09:40AM	Solventum (SOLV) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Feb-28-26 08:05PM	Solventum Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 05:07PM	Analyst Report: Solventum Corporation (Morningstar Research)
04:30PM	Loading…
04:30PM	Solventum Beat Wall Street Earnings Estimates. The Stock Falls. (Barrons.com)
12:48PM	OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts (Zacks)
12:45PM	Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down (Zacks)
08:12AM	Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. (Barrons.com)
12:05AM	Solventum Corp (SOLV) Q4 2025 Earnings Call Highlights: Strong Organic Growth Amid Margin Challenges (GuruFocus.com)
Feb-26-26 05:30PM	Solventum (SOLV) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
05:30PM	Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:17PM	Solventum's (NYSE:SOLV) Q4 CY2025 Sales Top Estimates (StockStory)
04:36PM	Solventum: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance (PR Newswire)
06:12AM	Loading…
Feb-25-26 06:12AM	What To Expect From Solventum's (SOLV) Q4 Earnings (StockStory)
Feb-23-26 09:15AM	Curious about Solventum (SOLV) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:45AM	Solventum to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-18-26 02:32AM	Activist Investor Nelson Peltz' Trian Fund Cut Back On This Stock In Q4, But Held Steady On GE Aerospace (Benzinga)
Feb-13-26 08:30PM	Analyst Report: Solventum Corporation (Morningstar Research)
Feb-11-26 07:46AM	Solventum Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-10-26 07:23PM	Analyst Report: Solventum Corporation (Morningstar Research)
Feb-08-26 12:18PM	Mizuho Upgrades Solventum (SOLV), Cites Optimistic Dental Outlook, Acera Acquisition (Insider Monkey)
Feb-03-26 07:46PM	Analyst Report: Solventum Corporation (Morningstar Research)
04:05PM	Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 (PR Newswire)
08:00AM	Here's Why Diamond Hill Large Cap Fund Added Solventum (SOLV) to Its Portfolio (Insider Monkey)
Jan-22-26 05:10AM	What You Need To Know Ahead of Solventum Earnings Release (Barchart)
Jan-20-26 05:28PM	Analyst Report: 3M Company (Morningstar Research)
Jan-13-26 11:05PM	3 Reasons SOLV is Risky and 1 Stock to Buy Instead (StockStory) -6.61%
03:30PM	JPM26: ThermoFisher very positive on strategic M&A as deals expand capabilities (Pharmaceutical Technology)
09:40AM	Loading…
Dec-30-25 09:40AM	Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? (Zacks)
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
Dec-23-25 04:05PM	Solventum Completes Acquisition of Acera Surgical (PR Newswire)
Dec-17-25 04:05PM	Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy (PR Newswire)
Dec-16-25 04:05PM	Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength (PR Newswire)
05:30AM	Is Solventum Stock Outperforming the Nasdaq? (Barchart)
Dec-10-25 08:38AM	Should You Add Solventum Corp (SOLV) to Your Portfolio? (Insider Monkey)
Dec-09-25 02:58PM	Solventum Corporation (SOLV): A Bull Case Theory (Insider Monkey)
Dec-05-25 11:53AM	BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing (Zacks)
03:35AM	These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? (Motley Fool)
Dec-04-25 11:46AM	HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency (Zacks)
Dec-01-25 06:43PM	Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity (MarketBeat)
Nov-25-25 04:05PM	Solventum to Participate in the 2025 Piper Sandler Healthcare Conference (PR Newswire)
Nov-24-25 04:38PM	Top Stock Reports for Alphabet, Roche & RTX (Zacks)
12:59PM	Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition (Medical Device Network)
Nov-21-25 03:35PM	Solventum Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
01:13PM	AI Stocks Are Taking a Beating. What to Buy Instead. (Barrons.com)
05:57AM	Solventum inks $725M Acera takeover (MedTech Dive)
Nov-20-25 09:00AM	Solventum Announces Agreement to Acquire Acera Surgical (PR Newswire)
09:00AM	Solventum Announces $1 Billion Share Repurchase Program (PR Newswire)
Nov-16-25 10:31PM	Unpacking Q3 Earnings: Solventum (NYSE:SOLV) In The Context Of Other Surgical Equipment & Consumables - Diversified Stocks (StockStory)
Nov-13-25 02:00PM	BDX Unveils Portable PureWick System for On-the-Go Incontinence Care (Zacks)
01:57PM	STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics (Zacks)
08:23AM	Solventum Stock: Analyst Estimates & Ratings (Barchart)
12:32AM	5 Must-Read Analyst Questions From Solventum's Q3 Earnings Call (StockStory)
Nov-12-25 11:40AM	SOLV vs. DHR: Which Stock Is the Better Value Option? (Zacks)
Nov-11-25 12:44PM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
12:00PM	Solventum (SOLV) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Nov-10-25 11:40AM	SOLV or DHR: Which Is the Better Value Stock Right Now? (Zacks)
07:03AM	Health-Insurer Stocks Drop After Trump Says ACA Funds Should Go to Public (The Wall Street Journal)
Nov-07-25 09:27AM	SOLV Q3 Deep Dive: Transformation Initiatives Drive Margin Gains Amid Tariff Headwinds (StockStory) +7.91%
08:40AM	SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook (Zacks)
12:07AM	Solventum Corp (SOLV) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Debt ... (GuruFocus.com)
Nov-06-25 06:00PM	Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Solventum (SOLV) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
05:01PM	Solventum's (NYSE:SOLV) Q3: Beats On Revenue (StockStory)
04:18PM	Solventum: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Solventum Reports Third Quarter 2025 Financial Results (PR Newswire)
10:39AM	XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View (Zacks)
08:35AM	Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View (Zacks)
08:31AM	MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down (Zacks)
Nov-05-25 11:54AM	Rigetti Computing to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
11:01AM	CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View (Zacks)
10:56AM	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves (Zacks)
10:53AM	FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y (Zacks)
09:15AM	Unveiling Solventum (SOLV) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-04-25 10:20PM	Solventum (SOLV) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
08:39AM	Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock? (Zacks)
08:39AM	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
08:38AM	Will Strong Segmental Performance Drive MCK's Top Line in Q2? (Zacks)
Nov-03-25 04:05PM	Solventum to Participate in the 2025 Stifel Healthcare Conference (PR Newswire)
Oct-31-25 01:53PM	DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised (Zacks)
10:18AM	SYK Stock Falls Despite Q3 Earnings & Sales Beat, '25 View Up (Zacks)
Oct-30-25 02:02PM	Avantor Stock Plunges as Q3 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
01:59PM	DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
01:56PM	TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
12:24PM	OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands (Zacks)
12:21PM	GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised (Zacks)
10:30AM	BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down (Zacks)
10:29AM	CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
10:00AM	Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 08:59AM	GE HealthCare Q3 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
Oct-28-25 05:14PM	Analyst Report: 3M Company (Morningstar Research)
12:10PM	Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
12:04AM	3 Reasons to Avoid SOLV and 1 Stock to Buy Instead (StockStory)
Oct-27-25 10:05AM	RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised (Zacks)
09:20AM	Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings? (Zacks)
Oct-24-25 08:45AM	What to Expect From Solventum's Next Quarterly Earnings Report (Barchart)
Oct-23-25 01:52AM	Solventum hires Heather Knight from Baxter to fill new C-suite post (MedTech Dive)

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wendell Amy McBride	Director	Mar 10 '26	Buy	68.03	1,475	100,344	5,039	Mar 11 06:31 AM
Landucci Amy	Chief Information Officer	Mar 06 '26	Option Exercise	0.00	3,795	0	39,214	Mar 09 07:49 PM
Harrington Paul S	Chief Supply Chain Officer	Mar 06 '26	Option Exercise	0.00	3,300	0	19,243	Mar 09 07:49 PM
McMillan Wayde D.	Chief Financial Officer	Mar 06 '26	Option Exercise	0.00	8,802	0	46,324	Mar 09 07:49 PM
Gomez Tammy L	Chief Human Resources Officer	Mar 06 '26	Option Exercise	0.00	3,300	0	11,965	Mar 09 07:48 PM
Hanson Bryan C	Chief Executive Officer	Mar 06 '26	Option Exercise	0.00	31,907	0	134,305	Mar 09 07:48 PM
Kirberger Marcela A.	Chief Legal Affairs Officer	Mar 06 '26	Option Exercise	0.00	4,180	0	12,236	Mar 09 07:47 PM
Hanson Bryan C	Chief Executive Officer	Sep 01 '25	Option Exercise	0.00	67,261	0	128,866	Sep 02 12:49 PM
3M CO	10% Owner	Aug 15 '25	Sale	73.45	8,800,000	646,360,000	25,569,190	Aug 18 05:02 PM
COX CARRIE SMITH	Director	May 13 '25	Option Exercise	0.00	5,148	0	5,148	May 15 04:23 PM
Hanson Bryan C	Chief Executive Officer	May 13 '25	Option Exercise	0.00	34,315	0	75,108	May 15 04:23 PM
Harris Bernard A Jr	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:23 PM
Edwards Shirley Ann	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:23 PM
Wilcox Mary T	Chief Accounting Officer	May 13 '25	Option Exercise	0.00	2,375	0	2,375	May 15 04:22 PM
DeVore Susan D.	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:22 PM
ALBAN CARLOS	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:22 PM
Harrington Paul S	Chief Supply Chain Officer	May 13 '25	Option Exercise	0.00	3,959	0	11,220	May 15 04:22 PM
Wendell Amy McBride	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:22 PM
MAY KAREN J	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:21 PM
Mily Elizabeth	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,626	May 15 04:21 PM
Gomez Tammy L	Chief Human Resources Officer	May 13 '25	Option Exercise	0.00	3,959	0	6,953	May 15 04:21 PM
Wilson Darryl L.	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:21 PM
WEILAND JOHN H	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:20 PM
EISENBERG GLENN A	Director	May 13 '25	Option Exercise	0.00	3,564	0	3,564	May 15 04:20 PM
McMillan Wayde D.	Chief Financial Officer	May 13 '25	Option Exercise	0.00	9,502	0	26,410	May 15 04:20 PM
Barry Chris	Executive Vice President	May 13 '25	Option Exercise	0.00	7,918	0	7,918	May 15 04:20 PM
Landucci Amy	Chief Information Officer	May 13 '25	Option Exercise	0.00	4,421	0	20,967	May 15 04:20 PM
Kirberger Marcela A.	Chief Legal Affairs Officer	May 13 '25	Option Exercise	0.00	4,487	0	7,056	May 15 04:17 PM

Open in Screener

ENTX

Entera Bio Ltd

Mar 11 • 09:30AM ET

1.49

0.00 0.00 %

Healthcare • Biotechnology • Israel • NASD

Peers: JNJ LLY AMGN BMY PFE SNY VRTX BIIB GSK NBIX

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	19.58%	Shs Outstand	45.66M	Perf Week	11.19%
Market Cap	68.33M	Forward P/E	-	EPS next Y	-0.68	Insider Trans	0.83%	Shs Float	36.88M	Perf Month	43.27%
Enterprise Value	51.94M	PEG	-	EPS next Q	-0.09	Inst Own	20.33%	Short Float	0.34%	Perf Quarter	-30.70%
Income	-10.78M	P/S	569.42	EPS this Y	-12.00%	Inst Trans	0.34%	Short Ratio	0.61	Perf Half Y	-25.50%
Sales	0.12M	P/B	4.47	EPS next Y	-142.86%	ROA	-85.74%	Short Interest	0.12M	Perf YTD	-23.20%
Book/sh	0.33	P/C	4.12	EPS next 5Y	-	ROE	-99.43%	52W High	3.22 -53.73%	Perf Year	-27.67%
Cash/sh	0.36	P/FCF	-	EPS past 3/5Y	18.40% 22.19%	ROIC	-70.58%	52W Low	1.00 49.00%	Perf 3Y	29.57%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.82% -5.17%	Gross Margin	-12.10%	Volatility	13.90% 11.04%	Perf 5Y	-63.12%
Dividend TTM	-	EV/Sales	432.83	EPS Y/Y TTM	5.96%	Oper. Margin	-8729.03%	ATR (14)	0.14	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.83	Sales Y/Y TTM	25.25%	Profit Margin	-8694.35%	RSI (14)	53.18	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.83	EPS Q/Q	15.21%	SMA20	3.44%	Beta	1.46	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	-0.55%	Rel Volume	1.21	Prev Close	1.49
Employees	20	LT Debt/Eq	0.00	Earnings	Nov 14 AMC	SMA200	-23.84%	Avg Volume	204.32K	Price	1.49
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.22% -	Trades		Volume	12,332	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-21	Initiated	Aegis Capital	Buy	$12

Mar-04-26 08:30AM	Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis (GlobeNewswire)
Feb-26-26 08:00AM	Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference (GlobeNewswire)
Feb-19-26 01:49AM	What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours (Benzinga)
Feb-11-26 09:00AM	Entera Bio Announces Open Market Purchases of Company Stock by Board Members (GlobeNewswire) +13.10%
Feb-09-26 08:50AM	Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones (GlobeNewswire) +27.88%
08:00AM	Loading…
Feb-04-26 08:00AM	OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism (GlobeNewswire)
Jan-21-26 08:30AM	Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook (GlobeNewswire)
Dec-23-25 08:30AM	Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA's Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation (GlobeNewswire) -6.38%
Dec-22-25 08:30AM	Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) (GlobeNewswire) +6.21%
Nov-18-25 08:00AM	Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference (GlobeNewswire)
Nov-14-25 04:05PM	Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Oct-23-25 08:50AM	Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women (GlobeNewswire) -6.96%
Oct-16-25 08:45AM	Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting (GlobeNewswire)
Sep-18-25 08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Aug-08-25 04:05PM	Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
04:05PM	Loading…
Jul-31-25 04:05PM	OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results (GlobeNewswire)
Jul-28-25 07:30AM	Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis (GlobeNewswire) +10.75%
Jul-08-25 08:00AM	OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress (GlobeNewswire)
Jun-26-25 08:00AM	Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting (GlobeNewswire)
Jun-25-25 08:00AM	OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting (GlobeNewswire)
May-09-25 04:05PM	Entera Bio Announces First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Apr-15-25 08:30AM	Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO (GlobeNewswire)
Mar-28-25 04:05PM	Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-18-25 11:37AM	Opko and Entera focus on oral care for obesity and metabolic disorders (Pharmaceutical Technology)
Mar-17-25 08:00AM	OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders (GlobeNewswire)
Feb-24-25 08:30AM	Entera Bio to Participate in Upcoming Events (GlobeNewswire)
Feb-19-25 08:00AM	EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (GlobeNewswire)
Jan-27-25 08:00AM	Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Nov-08-24 05:15PM	Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates (GlobeNewswire)
08:30AM	Loading…
Sep-25-24 08:30AM	Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders (GlobeNewswire)
Sep-18-24 09:40AM	Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-02-24 09:40AM	Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? (Zacks)
Aug-20-24 08:00AM	Entera Bio to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire)
Aug-15-24 12:00PM	All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy (Zacks)
Aug-09-24 04:05PM	Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-24 08:30AM	Entera's EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected (GlobeNewswire)
Jul-23-24 06:28AM	3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years (InvestorPlace)
Jul-08-24 03:53PM	3 Meme Stocks That Can Surge by 200% Before 2025 (InvestorPlace) +5.99%
Jul-02-24 05:05PM	3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns (InvestorPlace)
Jun-25-24 04:37PM	3 Meme Stocks to Buy on the Dip: June 2024 (InvestorPlace) -9.22%
Jun-20-24 12:38PM	7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months (InvestorPlace)
06:47AM	Rags to Riches: 3 Penny Stocks That Could Make Early Investors Rich (InvestorPlace)
06:47AM	Rag to Riches: 3 Penny Stocks That Could Make Early Investors Rich (InvestorPlace)
Jun-17-24 01:00PM	3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024 (InvestorPlace)
Jun-10-24 07:22PM	Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 (InvestorPlace)
Jun-07-24 07:30AM	Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar (InvestorPlace)
Jun-03-24 09:40AM	Has Entera Bio (ENTX) Outpaced Other Medical Stocks This Year? (Zacks)
08:00AM	Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024 (GlobeNewswire)
May-23-24 06:45AM	The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom (InvestorPlace)
May-16-24 09:40AM	Are Medical Stocks Lagging Entera Bio (ENTX) This Year? (Zacks)
May-15-24 08:00AM	Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member (GlobeNewswire)
May-13-24 07:00AM	Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024 (GlobeNewswire)
May-10-24 08:53PM	ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024 (InvestorPlace)
04:10PM	Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-26-24 06:00PM	Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Apr-18-24 06:15PM	Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today (Zacks) -11.16%
Apr-15-24 03:43PM	Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? (InvestorPlace) -15.44%
Apr-12-24 09:40AM	Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? (Zacks) +12.03%
Apr-09-24 09:09AM	Here's Why You Should Invest in Entera Bio (ENTX) Stock Now (Zacks) +15.38%
Apr-08-24 08:30AM	Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research (GlobeNewswire)
Mar-26-24 08:30AM	Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months (GlobeNewswire)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-20-24 08:00AM	Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome (GlobeNewswire) +7.79%
Mar-08-24 04:05PM	Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire) +5.04%
Mar-04-24 08:30AM	Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +19.44%
Jan-30-24 08:30AM	Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-03-24 08:00AM	Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
Dec-26-23 08:00AM	Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025 (GlobeNewswire)
Nov-29-23 08:30AM	Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera's Next Generation Oral Peptide Platform (GlobeNewswire)
Nov-14-23 07:30AM	Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development (GlobeNewswire)
Nov-09-23 02:30PM	Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis (GlobeNewswire) +20.64%
Oct-16-23 08:00AM	Entera Bio Reports Rapid Pharmacodynamic (PD) Response and Consistent Pharmacokinetic (PK) Data for its First-in-Class Oral PTH(1-34) Mini Tablets at the ASBMR 2023 Annual Meeting (GlobeNewswire)
Sep-13-23 01:18PM	OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations (Zacks)
Sep-12-23 08:30AM	Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes (GlobeNewswire)
Sep-05-23 08:00AM	Entera Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-23 08:30AM	Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting (GlobeNewswire) +5.02%
Aug-11-23 04:05PM	Entera Bio Announces Q2 2023 Financial Results and Corporate Updates (GlobeNewswire) -17.57%
Jun-07-23 07:30AM	Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors (GlobeNewswire)
May-07-23 08:10AM	Entera Bio First Quarter 2023 Earnings: US$0.076 loss per share (vs US$0.13 loss in 1Q 2022) (Simply Wall St.)
May-05-23 05:15PM	Entera Bio Ltd. (ENTX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.70% +7.30%
04:05PM	Entera Bio Announces Q1 2023 Financial Results and Corporate Updates (GlobeNewswire)
May-04-23 10:00AM	Will Entera Bio Ltd. (ENTX) Report Negative Q1 Earnings? What You Should Know (Zacks)
May-03-23 09:34AM	Enteras Oral Delivery of GLP-2 Pre-Clinical Data to be Published in Peer Reviewed, International Journal of Peptide Research and Therapeutics (GlobeNewswire) +10.00%
Apr-26-23 08:30AM	Menopause Luminary, Dr. Steven R. Goldstein, Joins Enteras Clinical and Scientific Advisory Board (GlobeNewswire)
Apr-03-23 07:00AM	Entera Bio Provides Guidance from FDA Type D Meeting Related to EB613 Pivotal Program (GlobeNewswire) -13.36%
Mar-31-23 05:15PM	Entera Bio Ltd. (ENTX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:00PM	Entera Bio Provides 2022 Corporate Milestones and Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Mar-23-23 09:27AM	Entera Bio Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Mar-10-23 08:05AM	Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely? (Simply Wall St.)
Feb-20-23 08:34AM	Entera Bio (ENTX) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-15-23 10:00AM	Entera Bio Announces FDAs Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis (GlobeNewswire) +10.99%
Feb-13-23 09:00AM	Entera Bio to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-10-23 06:00PM	Entera Bio Ltd. (ENTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-02-23 06:00PM	Entera Bio Ltd. (ENTX) Flat As Market Gains: What You Should Know (Zacks)
Jan-27-23 06:00PM	Entera Bio Ltd. (ENTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-25-23 06:15PM	Entera Bio Ltd. (ENTX) Flat As Market Sinks: What You Should Know (Zacks)
Jan-18-23 06:15PM	Entera Bio Ltd. (ENTX) Gains As Market Dips: What You Should Know (Zacks)
Nov-16-22 07:27AM	New Strong Buy Stocks for November 16th (Zacks) +15.76%
Nov-10-22 05:45PM	Entera Bio Ltd. (ENTX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -19.20%

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Germano Geno J	Director	Mar 09 '26	Buy	1.30	20,000	26,000	40,000	Mar 11 08:30 AM
Ellis Sean	Director	Mar 05 '26	Buy	1.23	10,000	12,300	188,098	Mar 09 08:30 AM
Rubin Steven D	Director	Feb 12 '26	Buy	1.49	5,000	7,450	15,000	Feb 17 08:30 AM
Rubin Steven D	Director	Feb 09 '26	Buy	1.20	10,000	12,000	10,000	Feb 11 08:44 AM
Ellis Sean	Director	Feb 09 '26	Buy	1.24	18,000	22,320	178,098	Feb 11 08:42 AM
Toledano Miranda Jayne	Chief Executive Officer	Dec 29 '25	Buy	1.81	11,000	19,912	426,575	Dec 30 06:01 AM
LIEBERMAN GERALD M	Director	Apr 01 '25	Option Exercise	1.00	23,952	23,952	300,160	Apr 03 04:06 PM

INDV Indivior Pharmaceuticals Inc daily Stock Chart

Peers: JNJ VRTX PFE ABBV BMY GILD LLY BIIB TEVA NBIX

| Held by: IJR IWM VXF SPSM IJT IWO SLYG VTWO SCHA VIOO

Index	RUT	P/E	19.93	EPS (ttm)	1.66	Insider Own	3.29%	Shs Outstand	125.00M	Perf Week	7.21%
Market Cap	4.14B	Forward P/E	9.63	EPS next Y	3.44	Insider Trans	0.12%	Shs Float	120.67M	Perf Month	-3.68%
Enterprise Value	4.30B	PEG	0.64	EPS next Q	0.65	Inst Own	94.95%	Short Float	8.30%	Perf Quarter	-5.77%
Income	209.00M	P/S	3.34	EPS this Y	23.71%	Inst Trans	1.07%	Short Ratio	4.30	Perf Half Y	33.77%
Sales	1.24B	P/B	-	EPS next Y	11.09%	ROA	16.53%	Short Interest	10.01M	Perf YTD	-7.76%
Book/sh	-0.78	P/C	21.23	EPS next 5Y	14.94%	ROE	-	52W High	38.00 -12.91%	Perf Year	238.74%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	- -	ROIC	97.66%	52W Low	8.64 283.04%	Perf 3Y	86.45%
Dividend Est.	-	EV/EBITDA	11.36	Sales past 3/5Y	11.20% 13.88%	Gross Margin	82.10%	Volatility	5.85% 4.23%	Perf 5Y	298.73%
Dividend TTM	-	EV/Sales	3.46	EPS Y/Y TTM	751.75%	Oper. Margin	29.03%	ATR (14)	1.41	Perf 10Y	198.15%
Dividend Ex-Date	-	Quick Ratio	0.55	Sales Y/Y TTM	4.38%	Profit Margin	16.85%	RSI (14)	48.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.71	EPS Q/Q	410.00%	SMA20	-0.36%	Beta	1.19	Target Price	46.86
Payout	0.00%	Debt/Eq	-	Sales Q/Q	20.13%	SMA50	-2.75%	Rel Volume	0.25	Prev Close	33.34
Employees	838	LT Debt/Eq	-	Earnings	Feb 26 BMO	SMA200	26.74%	Avg Volume	2.33M	Price	33.10
IPO	Dec 29, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.66% 17.14%	Trades		Volume	29,670	Change	-0.73%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Initiated	H.C. Wainwright	Buy	$27
Jul-22-25	Resumed	Jefferies	Buy	$20
Jan-28-25	Initiated	Rodman & Renshaw	Buy	$16
Jul-23-24	Initiated	Piper Sandler	Overweight	$22
Apr-03-24	Initiated	Craig Hallum	Buy	$37
Jul-13-23	Initiated	Northland Capital	Outperform	$35

Today 09:00AM	New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder (GlobeNewswire)
Mar-09-26 12:35PM	Implied Volatility Surging for Indivior Pharmaceuticals Stock Options (Zacks)
Feb-26-26 08:05PM	Indivior PLC Q4 2025 Earnings Call Summary (Moby)
09:55AM	Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates (Zacks)
09:16AM	Indivior Q4 Earnings Call Highlights (MarketBeat)
07:00AM	Loading…
07:00AM	Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results (GlobeNewswire)
Feb-24-26 07:00AM	Indivior to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-19-26 09:45AM	Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-28-26 07:00AM	Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? (GlobeNewswire)
Jan-26-26 07:00AM	Indivior Announces Completion of Redomiciliation to the United States (GlobeNewswire)
Jan-21-26 07:17AM	Strength Seen in Ardelyx (ARDX): Can Its 15.0% Jump Turn into More Strength? (Zacks)
04:54AM	'Follow The Money,' Not The Tariff Noise, Says Expert, Spotlights This New S&P Data Center Cooling Stock Among Top Picks (Benzinga)
Jan-13-26 09:19AM	Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes (Zacks)
Jan-12-26 10:14AM	PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates (Zacks)
10:08AM	TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug (Zacks)
08:43AM	Loading…
08:43AM	Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus (Zacks)
Jan-10-26 02:57PM	Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance (Insider Monkey)
Jan-09-26 11:46AM	AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations (Zacks)
Jan-08-26 11:09AM	GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug (Zacks)
08:57AM	4 Stocks Trading Near 52-Week High With Room to Rise Further (Zacks)
07:00AM	Indivior Provides Full-Year 2026 Financial Guidance and Business Update (GlobeNewswire)
Jan-07-26 11:45AM	FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug (Zacks)
09:53AM	OTLK Stock Crashes 67% in a Week: Here's What You Need to Know (Zacks)
Jan-06-26 11:53AM	ALT Stock Up 17% After Pemvidutide Gets FDA Breakthrough Tag for MASH (Zacks)
Dec-30-25 10:32AM	Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher (Barchart)
Dec-22-25 07:00AM	Indivior Announces Inclusion in the S&P SmallCap 600 Index (PR Newswire)
06:00AM	2026 outlook: Small-cap biotechs may fill gaps on drug pipelines (Yahoo Finance Video)
Dec-17-25 11:30AM	New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations (PR Newswire)
Dec-05-25 05:49PM	CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Nov-20-25 04:01PM	Indivior Concludes Legacy U.S. Department of Justice Matter (PR Newswire)
09:21AM	Loading…
Nov-19-25 09:21AM	Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-07-25 08:37AM	4 Must-Buy Efficient Stocks to Enrich Your Portfolio in 2025 (Zacks)
Nov-06-25 03:25PM	3 Top Ranked Stocks that are the Best of the Best (Zacks)
Nov-03-25 08:00AM	Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine (PR Newswire) +6.23%
Oct-31-25 10:03AM	Indivior (INDV) Jumps to New High on Earnings Blowout, Optimistic Outlook (Insider Monkey)
Oct-30-25 04:22PM	Indivior PLC (INDV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +15.41%
02:18PM	Here's Why Indivior Stock Soared 15% Today (Motley Fool)
08:30AM	Indivior PLC (INDV) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:00AM	Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance (PR Newswire)
Oct-29-25 09:40AM	Indivior PLC (INDV) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-28-25 10:00AM	Indivior to Participate in the Stifel 2025 Healthcare Conference (PR Newswire)
Oct-23-25 09:21AM	Indivior PLC (INDV) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-16-25 04:04PM	Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th (PR Newswire)
Oct-15-25 08:00AM	Clinical Evidence Supports Rapid SUBLOCADE Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment (PR Newswire)
Oct-01-25 08:00AM	Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation (PR Newswire)
Sep-30-25 12:47PM	Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M (Insider Monkey)
Sep-10-25 12:00PM	What Makes Indivior PLC (INDV) a Strong Momentum Stock: Buy Now? (Zacks)
Sep-09-25 11:57AM	Top 100 Stocks to Buy: Indivior Advances Into Top 50 on Momentum (Barchart)
Aug-20-25 12:00PM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
Aug-06-25 09:36AM	Snap downgraded, Leidos upgraded: Wall Street's top analyst calls (The Fly)
Aug-05-25 12:00PM	All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy (Zacks)
10:00AM	Best Momentum Stock to Buy for August 5th (Zacks)
06:16AM	New Strong Buy Stocks for August 5th (Zacks)
Aug-03-25 12:32PM	Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook (Insider Monkey)
Aug-01-25 01:23PM	Indivior (INDV) Extends Jump on 3rd Day with 16% Gain (Insider Monkey)
Jul-31-25 08:15AM	Indivior PLC (INDV) Tops Q2 Earnings and Revenue Estimates (Zacks) +16.09%
07:00AM	Indivior Reports Second Quarter 2025 Financial Results and Raises FY 2025 Financial Guidance (PR Newswire)
Jul-30-25 09:43AM	Indivior PLC (INDV) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-28-25 10:06AM	Indivior PLC (INDV) Reinvents Leadership, Moves Listing to Nasdaq (Insider Monkey)
10:00AM	BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-25-25 02:00AM	Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
Jul-24-25 10:00AM	Indivior PLC (INDV) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-25 08:00AM	Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder (PR Newswire)
Jul-17-25 09:00AM	Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on July 31st (PR Newswire)
Jul-08-25 08:00AM	Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs (PR Newswire)
Jul-01-25 07:05AM	Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Jun-30-25 07:00AM	Indivior Announces Inclusion in the U.S. Russell 2000 and 3000 Indexes (PR Newswire) +5.66%
Jun-27-25 05:45PM	IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Jun-24-25 04:12PM	Indivior Appoints Tony Kingsley to the Board of Directors (PR Newswire)
02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Jun-20-25 03:01AM	Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Jun-19-25 09:00AM	Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users (PR Newswire)
Jun-05-25 05:08AM	Wise Plans to Shift Main Listing to US in Latest London Loss (Bloomberg)
Jun-02-25 05:24AM	FTSE pharma giant joins London stock market exodus (The Telegraph)
02:00AM	Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
May-27-25 08:30AM	Indivior Announces Patrick Barry as Chief Commercial Officer (PR Newswire) +5.02%
May-13-25 10:00AM	Indivior to Participate in Upcoming Investor Events (PR Newswire)
May-01-25 10:27AM	New Study Highlights Monthly SUBLOCADE as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy (PR Newswire)
Apr-28-25 12:12PM	Indivior: Trying To Break Addiction (Seeking Alpha)
Apr-24-25 10:45AM	Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha) +13.86%
07:05AM	Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates (Zacks)
03:58AM	Indivior Q1 Net Income Declines; Net Revenue Down 6% (RTT News)
02:00AM	Indivior Announces Q1 2025 Financial Results (PR Newswire)
Apr-02-25 04:12AM	Indivior: A Complicated Story Of Both Declining Revenue And Strong Financials (Seeking Alpha)
Mar-31-25 07:51PM	Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks' Oaktree Capital Management? (Insider Monkey)
Mar-27-25 05:35PM	Plus Therapeutics (PSTV) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-04-25 08:40AM	Indivior Announces Further Changes to Board of Directors (PR Newswire) +5.76%
Mar-02-25 06:36PM	Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-27-25 02:00AM	Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer (PR Newswire)
Feb-24-25 02:00AM	Indivior Announces FDA Approval of Label Changes for SUBLOCADE (buprenorphine extended-release) Injection (PR Newswire)
Feb-21-25 02:05AM	Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ... (GuruFocus.com) -6.01%
Feb-20-25 02:13PM	European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat (Benzinga) -17.60%
09:11AM	Earnings To Watch: Indivior PLC (INDV) Reports Q4 2024 Result (GuruFocus.com)
07:05AM	Indivior PLC (INDV) Q4 Earnings Meet Estimates (Zacks)
02:00AM	Indivior Announces FY and Q4 2024 Financial Results (PR Newswire)
Feb-13-25 10:01AM	Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-12-25 02:00AM	Indivior Statement RE: Delayed FDA Approval of SUBLOCADE Label Changes (PR Newswire)
Jan-31-25 08:33AM	Heres Summers Value Partners Investment Thesis for Indivior (INDV) (Insider Monkey)

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ryan Barbara	Director	Mar 09 '26	Buy	32.56	31	1,009	5,716	Mar 11 08:12 AM
Ryan Barbara	Director	Jan 05 '26	Buy	35.39	775	27,429	1,963	Jan 07 01:51 PM
Humphreys Keith	Director	Jan 05 '26	Buy	35.39	775	27,429	5,802	Jan 07 01:50 PM
NINIVAGGI DANIEL A	Director	Jan 05 '26	Buy	35.39	775	27,429	16,923	Jan 07 01:49 PM
Stejbach Mark	Director	Jan 05 '26	Buy	35.39	775	27,429	16,847	Jan 07 01:48 PM
Wheadon David E.	Director	Jan 05 '26	Buy	35.39	1,771	62,680	14,395	Jan 07 01:47 PM
Cetani Cynthia C	Officer	Nov 07 '25	Proposed Sale	30.65	121,737	3,731,762		Nov 07 04:05 PM
Crossley Mark	Affiliate	Sep 08 '25	Proposed Sale	24.75	26,463	655,000		Sep 08 04:26 PM
Mark Crossley	affiliate	Sep 08 '25	Proposed Sale	24.97	183,938	4,593,151		Sep 08 02:24 PM
Mark Crossley	affiliate	Sep 04 '25	Proposed Sale	24.80	30,000	744,010		Sep 04 12:59 PM
Mark Crossley	affiliate	Aug 28 '25	Proposed Sale	24.43	52,320	1,278,178		Aug 28 12:15 PM

Open in Screener

CSTM

Constellium SE

Mar 11 • 09:30AM ET

25.42

-0.07 -0.26 %

Basic Materials • Aluminum • France • NYSE

Peers: AA KALU RS ATI STLD NUE X TX CENX CMC

| Held by: IWM AVDV IWN VTWO IWO FNDC VAW AVDE JSMD TSCV

Index	RUT	P/E	13.14	EPS (ttm)	1.93	Insider Own	11.22%	Shs Outstand	135.42M	Perf Week	-1.57%
Market Cap	3.43B	Forward P/E	10.87	EPS next Y	2.34	Insider Trans	-1.39%	Shs Float	119.92M	Perf Month	2.77%
Enterprise Value	5.40B	PEG	-	EPS next Q	0.58	Inst Own	83.15%	Short Float	5.95%	Perf Quarter	43.08%
Income	273.00M	P/S	0.41	EPS this Y	62.74%	Inst Trans	-2.63%	Short Ratio	3.76	Perf Half Y	77.42%
Sales	8.45B	P/B	3.62	EPS next Y	16.27%	ROA	5.41%	Short Interest	7.14M	Perf YTD	34.88%
Book/sh	7.03	P/C	28.62	EPS next 5Y	-	ROE	32.93%	52W High	27.41 -7.24%	Perf Year	114.74%
Cash/sh	0.89	P/FCF	20.94	EPS past 3/5Y	-4.42% -	ROIC	9.24%	52W Low	7.32 247.10%	Perf 3Y	70.52%
Dividend Est.	-	EV/EBITDA	6.71	Sales past 3/5Y	-0.37% 8.68%	Gross Margin	10.14%	Volatility	5.24% 5.16%	Perf 5Y	51.79%
Dividend TTM	-	EV/Sales	0.64	EPS Y/Y TTM	508.56%	Oper. Margin	5.61%	ATR (14)	1.28	Perf 10Y	269.55%
Dividend Ex-Date	-	Quick Ratio	0.51	Sales Y/Y TTM	15.22%	Profit Margin	3.23%	RSI (14)	54.50	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.29	EPS Q/Q	340.18%	SMA20	0.63%	Beta	1.46	Target Price	29.00
Payout	0.00%	Debt/Eq	2.17	Sales Q/Q	27.89%	SMA50	8.76%	Rel Volume	0.16	Prev Close	25.49
Employees	11500	LT Debt/Eq	2.10	Earnings	Feb 18 BMO	SMA200	48.93%	Avg Volume	1.90M	Price	25.42
IPO	May 23, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	105.49% 6.73%	Trades		Volume	15,011	Change	-0.26%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-26	Upgrade	Wells Fargo	Equal Weight → Overweight	$25
Oct-08-25	Initiated	Wells Fargo	Equal Weight	$16
Feb-25-25	Upgrade	Deutsche Bank	Hold → Buy	$15
Oct-24-24	Downgrade	Deutsche Bank	Buy → Hold	$22 → $12
Jan-16-24	Initiated	UBS	Buy	$27
May-08-23	Initiated	JP Morgan	Overweight	$24
Dec-10-21	Downgrade	JP Morgan	Overweight → Neutral	$22 → $21
Nov-17-21	Initiated	Wolfe Research	Outperform	$24
Sep-10-21	Initiated	Goldman	Buy	$25
Apr-23-21	Initiated	JP Morgan	Overweight	$18
Mar-22-21	Upgrade	Northland Capital	Market Perform → Outperform	$14 → $21
Feb-08-21	Downgrade	Northland Capital	Outperform → Market Perform
Dec-17-20	Upgrade	BMO Capital Markets	Market Perform → Outperform	$18
Jan-16-20	Initiated	The Benchmark Company	Buy	$17
Jan-13-20	Initiated	Northland Capital	Outperform	$19
Oct-30-18	Upgrade	Societe Generale	Hold → Buy
Jul-16-18	Initiated	Jefferies	Buy	$14
Apr-27-18	Upgrade	Seaport Global Securities	Neutral → Buy	$14 → $16
Mar-20-18	Initiated	Goldman	Buy	$16
Feb-28-18	Downgrade	Societe Generale	Buy → Hold

Show Previous Ratings

Mar-10-26 05:18AM	Zacks.com featured highlights include BrightSpring Health, Constellium, Strategic Education and Astronics (Zacks)
Mar-09-26 08:10AM	4 Top-Ranked Stocks With Solid Net Profit Margin to Enhance Returns (Zacks)
Mar-03-26 06:00AM	Constellium Releases 2025 Sustainability Report, Shaping the Future of Sustainable Aluminum (GlobeNewswire)
Feb-27-26 11:12AM	Rising Costs & Expenses Pressure Alcoa: What's the Road Ahead? (Zacks)
Feb-25-26 10:07AM	Alcoa vs. Constellium: Which Aluminum Stock has Greater Upside? (Zacks) +5.01%
12:00PM	Loading…
Feb-24-26 12:00PM	Constellium (CSTM) Is Up 9.23% in One Week: What You Should Know (Zacks)
08:55AM	Here's What Could Help Constellium (CSTM) Maintain Its Recent Price Strength (Zacks)
Feb-23-26 10:15AM	Best Momentum Stocks to Buy for February 23rd (Zacks)
09:40AM	Is Century Aluminum (CENX) Stock Outpacing Its Industrial Products Peers This Year? (Zacks)
09:40AM	Should Value Investors Buy Constellium (CSTM) Stock? (Zacks)
08:55AM	Fast-paced Momentum Stock Constellium (CSTM) Is Still Trading at a Bargain (Zacks)
04:21AM	New Strong Buy Stocks for February 23rd (Zacks)
Feb-19-26 10:20AM	Alcoa's Alumina Segment Growth Picks Up: More Upside to Come? (Zacks)
06:10AM	Constellium (CSTM) Hits New Decade-High on Impressive Earnings (Insider Monkey)
Feb-18-26 04:31PM	Constellium SE Q4 2025 Earnings Call Summary (Moby) +9.53%
04:05PM	Loading…
04:05PM	Constellium SE (CSTM) Q4 2025 Earnings Call Highlights: Record Revenue and Net Income Surge ... (GuruFocus.com)
12:49PM	Constellium Q4 Earnings Call Highlights (MarketBeat)
07:10AM	Constellium (CSTM) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:00AM	Constellium Reports Strong Fourth Quarter and Full Year 2025 Results; Provides Full Year 2026 Guidance (GlobeNewswire)
Feb-12-26 12:47PM	Alcoa Surges 65.4% in 3 Months: Is the Stock Still Worth Buying? (Zacks)
Feb-11-26 10:09AM	Alcoa's Aluminum Segment Growth Picks Up: More Upside to Come? (Zacks)
Jan-28-26 06:00AM	Constellium to Report Fourth Quarter and Full Year 2025 Results on February 18, 2026 (GlobeNewswire)
Jan-19-26 12:59PM	Alcoa Q4 Earnings on the Deck: How to Approach the Stock Now? (Zacks)
Jan-15-26 10:32AM	Alcoa's Alumina Segment Gains Momentum: Can it Sustain? (Zacks)
Jan-12-26 11:19AM	While Everyone Chases Copper, Another Metal Soared $1,000 Per Ton Since April (24/7 Wall St.) +5.04%
10:11AM	Deutsche Bank Hikes Constellium (CSTM) PT to $25 Amid Sector-Wide Metals Rally (Insider Monkey)
Jan-09-26 10:15AM	Alcoa Surges 93.5% in 6 Months: Should You Buy the Stock Now? (Zacks)
Jan-05-26 09:05AM	Alcoa's Aluminum Segment Gains Momentum: Can it Sustain? (Zacks)
Dec-03-25 04:00AM	Constellium Inaugurates New Finishing Lines at Singen, Marking Completion of Major Investment (GlobeNewswire) +6.45%
Oct-30-25 03:52PM	Constellium SE (CSTM) Q3 2025 Earnings Call Highlights: Record Revenue and EBITDA Amid Market ... (GuruFocus.com)
07:25AM	Loading…
Oct-29-25 07:25AM	Constellium (CSTM) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:15AM	Constellium Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Guidance (GlobeNewswire)
06:00AM	Constellium Appoints Ingrid Joerg as its New Chief Executive Officer, Effective January 1, 2026 (GlobeNewswire)
Oct-28-25 09:42AM	Constellium SE (CSTM) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-22-25 10:00AM	Constellium (CSTM) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-14-25 08:00AM	Constellium to Report Third Quarter 2025 Results on October 29, 2025 (GlobeNewswire)
Sep-26-25 09:40AM	Are Industrial Products Stocks Lagging Century Aluminum (CENX) This Year? (Zacks)
08:50AM	Why Fast-paced Mover Constellium (CSTM) Is a Great Choice for Value Investors (Zacks)
Sep-10-25 09:40AM	Are Investors Undervaluing Constellium (CSTM) Right Now? (Zacks) +5.54%
09:40AM	Is Century Aluminum (CENX) Stock Outpacing Its Industrial Products Peers This Year? (Zacks)
Sep-09-25 06:00AM	Constellium Extends Partnership with Embraer for Advanced Aluminum Aerospace Solutions (GlobeNewswire)
Sep-03-25 03:00AM	Constellium to Showcase Advanced Aluminum Solutions from Collaborative Research Project "CirConAl" at Cenex 2025 (GlobeNewswire)
Aug-01-25 09:40AM	Should Value Investors Buy Constellium (CSTM) Stock? (Zacks)
09:40AM	Are Industrial Products Stocks Lagging Broadwind Energy (BWEN) This Year? (Zacks)
Jul-30-25 03:13AM	Constellium SE (CSTM) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Profit Decline (GuruFocus.com)
Jul-29-25 07:15AM	Constellium (CSTM) Q2 Earnings Lag Estimates (Zacks) +5.38%
06:00AM	Constellium Reports Second Quarter and First Half 2025 Results; Raises Full Year 2025 Guidance (GlobeNewswire)
Jul-28-25 09:28AM	Constellium SE (CSTM) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-22-25 10:00AM	Earnings Preview: Constellium (CSTM) Q2 Earnings Expected to Decline (Zacks)
Jul-17-25 02:59AM	Constellium Achieves Sustainable Milestone with Aircraft Aluminum Recycling (Insider Monkey)
Jul-15-25 06:30AM	Constellium Drives Digital and Modular Innovation for Smart Aluminum Automotive Structures with ARENA2036 (GlobeNewswire)
Jul-11-25 07:00AM	Constellium to Report Second Quarter 2025 Results on July 29, 2025 (GlobeNewswire)
Jun-24-25 07:30AM	Constellium Honored with Three Supplier Awards from Airbus (GlobeNewswire)
Jun-18-25 12:33PM	Supply chain fog clearing for plane suppliers, Constellium says (Reuters)
Jun-16-25 01:00AM	Constellium to Exhibit at the 2025 Paris Air Show (GlobeNewswire)
Jun-12-25 06:00AM	Constellium and TARMAC Aerosave Achieve Breakthrough in Full-Circular Aluminum Recycling for End-of-Life Aircraft (GlobeNewswire)
Jun-05-25 07:00AM	Constellium Joins America Makes Project to Advance Use of Aluminum Additive Manufacturing in Defense and Aerospace (GlobeNewswire)
May-28-25 11:04AM	Alcoa Rises 12.1% in a Month: Should You Buy the Stock Now or Wait? (Zacks)
07:00AM	NASA Visits Constellium Ravenswood to Celebrate Artemis Partnership (GlobeNewswire)
May-23-25 05:00AM	Voting Results from Constellium's 2025 Annual General Meeting (GlobeNewswire)
May-15-25 11:21AM	Alcoa vs. Constellium: Which Aluminum Stock is a Stronger Play Now? (Zacks)
May-07-25 12:30PM	Trimble Earnings Surpass Estimates in Q1, Revenues Decline Y/Y (Zacks)
May-06-25 09:55AM	Wall Street Analysts See a 50.36% Upside in Constellium (CSTM): Can the Stock Really Move This High? (Zacks)
08:50AM	Despite Fast-paced Momentum, Constellium (CSTM) Is Still a Bargain Stock (Zacks)
May-02-25 12:45PM	3 Reasons Growth Investors Will Love Constellium (CSTM) (Zacks)
09:40AM	Are Investors Undervaluing Constellium (CSTM) Right Now? (Zacks)
May-01-25 03:13AM	Constellium SE (CSTM) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Market Challenges (GuruFocus.com) +6.63%
01:47AM	Q1 2025 Constellium SE Earnings Call (Thomson Reuters StreetEvents)
Apr-30-25 05:14PM	Constellium SE (CSTM) Q1 2025 Earnings Call Transcript (Seeking Alpha) +5.42%
07:10AM	Constellium (CSTM) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:10AM	Constellium: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Constellium Reports First Quarter 2025 Results and Maintains Full Year 2025 Guidance (GlobeNewswire)
Apr-16-25 10:01AM	Constellium (CSTM) Q1 Earnings Preview: What's in the Cards? (Zacks)
08:00AM	Constellium to Report First Quarter 2025 Results on April 30, 2025 (GlobeNewswire)
Apr-15-25 08:30AM	Constellium posts 2025 Annual General Meeting Materials (GlobeNewswire)
Mar-25-25 07:47AM	Fidelity Freedom Income Fund Q4 2024 Review (SeekingAlpha)
Mar-21-25 11:55AM	Here's How Investors Should Play Alcoa Stock Amid Tariff Risks (Zacks)
Mar-19-25 01:48PM	Is Constellium SE (CSTM) the Best Aluminum Stock to Buy According to Billionaires? (Insider Monkey)
Mar-04-25 06:00AM	Constellium Releases 2024 Sustainability Report, Advancing a Sustainable Economy Together (GlobeNewswire)
Feb-25-25 11:53AM	Gordon Murray to develop ultra-lightweight, eco-friendly vehicle chassis (Just Auto) +5.54%
Feb-24-25 08:00AM	Constellium Joins Industry Consortium for Lightweight Vehicle Chassis Innovation Project (GlobeNewswire)
Feb-21-25 10:41AM	Should You Expect Strong Demand for Constellium SE (CSTM)? (Insider Monkey)
01:04AM	Q4 2024 Constellium SE Earnings Call (Thomson Reuters StreetEvents)
Feb-20-25 09:10AM	What To Expect From Constellium SE (CSTM) Q4 2024 Earnings (GuruFocus.com) +14.22%
07:10AM	Constellium (CSTM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:24AM	Constellium: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Constellium Reports Fourth Quarter and Full Year 2024 Results; Establishes New Long-Term Targets (GlobeNewswire)
Feb-18-25 08:00AM	Constellium Announces Price Increase for Shipments of Flat Rolled Products in the US (GlobeNewswire)
Feb-13-25 10:01AM	Earnings Preview: Constellium (CSTM) Q4 Earnings Expected to Decline (Zacks)
Feb-05-25 08:00AM	Constellium to Report Fourth Quarter and Full Year 2024 Results on February 20, 2025 (GlobeNewswire)
Jan-15-25 08:00AM	Constellium to Voluntarily Transition to Reporting in U.S. Dollars Under U.S. GAAP; Will Begin Filing Annual Reports on Form 10-K (GlobeNewswire) +6.58%
Dec-12-24 08:30AM	Constellium and Renault Group Conclude RandD Project Advancing Aluminium Solutions for Lighter Vehicles and Closed-Loop Recycling (GlobeNewswire)
08:30AM	Constellium and Renault Group Conclude R&D Project Advancing Aluminium Solutions for Lighter Vehicles and Closed-Loop Recycling (GlobeNewswire)
Dec-04-24 08:34AM	Why Constellium (CSTM) is the Best Aluminum and Aluminum Mining Stock To Buy? (Insider Monkey)
Nov-21-24 07:00PM	2 Stocks to Buy as China Tightens Its Grip on Critical Minerals (Oilprice.com)
08:00AM	Constellium Receives France 2030 Award for the Wing of the Future Project on the Design of the Sustainable Aircraft of Tomorrow (GlobeNewswire)
Nov-19-24 08:00AM	First Aluminium Coils from Constellium's New Recycling Center in Neuf-Brisach Qualified by Crown (GlobeNewswire)
Nov-12-24 08:00AM	Constellium Successfully Sorts Automotive Aluminium Scrap with LIBS Technology at Industrial Scale (GlobeNewswire)
Oct-24-24 05:00AM	Constellium SE (CSTM) Q3 2024 Earnings Call Highlights: Navigating Challenges Amid Market Headwinds (GuruFocus.com)
Oct-23-24 07:10AM	Constellium (CSTM) Lags Q3 Earnings and Revenue Estimates (Zacks) -28.13%

Constellium SE is a holding company, which engages in the design and manufacture of rolled and extruded aluminum products. It operates through the following segments: Packaging and Automotive Rolled Products, Aerospace and Transportation, and Automotive Structures and Industry. The Packaging and Automotive Rolled Products segment includes the production in European and North American facilities. The Aerospace and Transportation segment involves the plate and sheet form, and limited volumes of extruded products. The Automotive Structures and Industry segment consists of extruded aluminum products and structural components, crash-management systems, body structures, side impact beams, and battery enclosures, fabricated hard and soft alloy extruded profiles. The company was founded on May 14, 2010 and is headquartered in Paris, France.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoffmann Philippe	President, A&T	Mar 10 '26	Sale	25.87	4,728	122,313	182,120	Mar 11 06:48 AM
Becker Marcus	SVP CPO	Mar 10 '26	Sale	25.87	1,113	28,793	33,237	Mar 11 06:44 AM
Joerg Ingrid	CEO	Mar 10 '26	Sale	25.87	4,614	119,364	378,090	Mar 11 06:34 AM
Guo Jack Q.	EVP & CFO	Mar 10 '26	Sale	25.87	41,717	1,079,219	190,879	Mar 11 06:33 AM
Jurkovic Philip Ryan	SVP & CHRO	Mar 10 '26	Sale	25.87	29,900	773,513	210,723	Mar 11 06:31 AM
Brun Nicolas	SVP PA, Comm & Sust	Mar 09 '26	Sale	24.67	17,701	436,684	103,466	Mar 11 06:27 AM
Stephane Corre	Affiliate	Mar 10 '26	Proposed Sale	25.89	1,500	38,828		Mar 10 04:17 PM
Ryan Jurkovic	Affiliate	Mar 10 '26	Proposed Sale	25.87	29,900	773,607		Mar 10 02:17 PM
Jack Guo	Affiliate	Mar 10 '26	Proposed Sale	25.87	41,717	1,079,349		Mar 10 02:13 PM
Ingrid Joerg	Affiliate	Mar 10 '26	Proposed Sale	25.87	4,614	119,379		Mar 10 02:10 PM
Philippe Hoffmann	Affiliate	Mar 10 '26	Proposed Sale	25.87	4,728	122,328		Mar 10 02:06 PM
Marcus Becker	Affiliate	Mar 10 '26	Proposed Sale	25.87	1,113	28,797		Mar 10 02:03 PM
Nicolas Brun	Affiliate	Mar 09 '26	Proposed Sale	24.67	17,701	436,679		Mar 09 03:53 PM
Hoffmann Philippe	President, A&T	Mar 04 '26	Sale	26.45	80,000	2,115,700	55,425	Mar 06 08:33 AM
Philippe Hoffmann	affiliate	Mar 04 '26	Proposed Sale	26.44	80,000	2,115,513		Mar 04 04:06 PM
Corre Stephane	President, AS&I	Feb 27 '26	Sale	24.69	3,000	74,070	44,444	Mar 03 09:13 AM
Stephane Corre	Affiliate	Feb 27 '26	Proposed Sale	24.69	3,000	74,066		Feb 27 03:24 PM
Boccon-Gibod Isabelle	Director	Feb 26 '26	Sale	25.77	10,000	257,700	23,000	Feb 27 09:12 AM
Corre Stephane	President, AS&I	Feb 25 '26	Sale	25.71	3,200	82,262	47,444	Feb 27 09:08 AM
Stephane Corre	Affiliate	Feb 25 '26	Proposed Sale	25.71	3,200	82,260		Feb 26 01:00 PM
Boccon-Gibod Isabelle	Director	Feb 25 '26	Proposed Sale	25.77	10,000	257,700		Feb 25 04:24 PM
Becker Marcus	Officer	Feb 20 '26	Proposed Sale	0.00	15,570	26		Feb 24 06:31 PM
Becker Marcus	SVP CPO	Feb 20 '26	Sale	25.58	15,570	398,270	0	Feb 24 08:48 AM
Walters Stephen Charles	SVP GC & Secretary	Feb 23 '26	Sale	25.39	1,500	38,085	0	Feb 24 08:46 AM

FOUR

Shift4 Payments Inc

SOLV

Solventum Corp

ENTX

Entera Bio Ltd

INDV

Indivior Pharmaceuticals Inc

CSTM

Constellium SE

Upgrade your FINVIZ experience